Furthermore, the authors found that high Egr2 and DGKα expression in NK cells infiltrating acute myeloid leukemia and glioma tumors was associated with significantly reduced patient survival compared to NK cells exhibiting low Egr2 and DGKα expression profiles. The gene discussed is EGR2; the disease is central nervous system cancer.